CLINICAL_TRIALS trial_result · 2018-05-14

Clinical Trial Update: A Study in Participants With Rheumatoid Arthritis [Phase 3]

Phase 3 trial in rheumatoid arthritis was terminated, with results posted on 2018-05-14.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2018-05-14